Friday , March 27th, 2026
Continental Breakfast
7:00 AM - 8:00 AM
Artificial Intelligence Enhances Skin Allergy Testing
GS310 8:00 AM - 9:00 AM
Speaker: Mikolaj A. Wieczorek, M.S.
Allergic contact dermatitis is an inflammatory skin response that affects about 1 in 5 people and is diagnosed using patch testing (PT). Traditional PT requires three in-person clinical appointments spread over 5 days using standardized allergen panels that are not tailored to a patient’s unique risk profile. The allergens are typically applied to the patient’s back, which necessitates that the test vehicle be removed and read by trained medical staff. This process creates long waits, specialist shortages, and substantial financial and logistical burdens for patients. Our personalized, AI-assisted approach reimagines PT by transitioning it from provider-led to patient-centered testing. Patches are placed on the volar forearm, allowing patients to easily access the test site and document reactions using a smartphone app. This solution expands access and reduces test burden while supporting providers through evidence-based allergen recommendations, AI-assisted interpretation, and automated documentation that together guide diagnosis.
Learning Objectives:
Describe key barriers in traditional patch testing workflows that affect access, cost, and documentation workload. Explain how an AI tool progresses from concept through clinical validation and phased early clinical implementation, using patch testing as an example. Understand the structure and outcomes of clinical trials evaluating AI-assisted, patient-centered patch testing, including how AI performance compares to human readers across different levels of medical training and variability. Discuss how AI-assisted patch testing may improve patient access, diagnostic accuracy, and clinical efficiency.
ANCC CE 1.0
Speaker: Mikolaj A. Wieczorek, M.S.
Allergic contact dermatitis is an inflammatory skin response that affects about 1 in 5 people and is diagnosed using patch testing (PT). Traditional PT requires three in-person clinical appointments spread over 5 days using standardized allergen panels that are not tailored to a patient’s unique risk profile. The allergens are typically applied to the patient’s back, which necessitates that the test vehicle be removed and read by trained medical staff. This process creates long waits, specialist shortages, and substantial financial and logistical burdens for patients. Our personalized, AI-assisted approach reimagines PT by transitioning it from provider-led to patient-centered testing. Patches are placed on the volar forearm, allowing patients to easily access the test site and document reactions using a smartphone app. This solution expands access and reduces test burden while supporting providers through evidence-based allergen recommendations, AI-assisted interpretation, and automated documentation that together guide diagnosis.
Learning Objectives:
Describe key barriers in traditional patch testing workflows that affect access, cost, and documentation workload. Explain how an AI tool progresses from concept through clinical validation and phased early clinical implementation, using patch testing as an example. Understand the structure and outcomes of clinical trials evaluating AI-assisted, patient-centered patch testing, including how AI performance compares to human readers across different levels of medical training and variability. Discuss how AI-assisted patch testing may improve patient access, diagnostic accuracy, and clinical efficiency.
ANCC CE 1.0
Infantile Hemangiomas
GS320 9:00 AM - 10:00 AM
Speaker: Sofia Guelfand Warnken, MD
Recognizing the most common vascular birthmarks in the pediatric population, identifying high-risk hemangiomas, and understanding their potential complications.
Learning Objectives:
Recognizing high risk infantile hemangiomas.
ANCC CE 1.0
Speaker: Sofia Guelfand Warnken, MD
Recognizing the most common vascular birthmarks in the pediatric population, identifying high-risk hemangiomas, and understanding their potential complications.
Learning Objectives:
Recognizing high risk infantile hemangiomas.
ANCC CE 1.0
Wound Care Dressings: The Basics
GS330 10:15 AM - 11:15 AM
Speaker: Savannah Elmore, LPN
This presentation will help Healthcare Providers better understand the basic wound care dressings that are available and on the market, and when to reach for which basic wound care dressings. This presentation will consist of a 30-minute educational lecture and a 30-minute hands-on portion.
Learning Objectives:
Describe basic wound care dressings that are on the market and available to patients. Recognize how and when to choose certain basic dressings. Demonstrate techniques of applying wound care basic dressings.
ANCC CE 1.0
Speaker: Savannah Elmore, LPN
This presentation will help Healthcare Providers better understand the basic wound care dressings that are available and on the market, and when to reach for which basic wound care dressings. This presentation will consist of a 30-minute educational lecture and a 30-minute hands-on portion.
Learning Objectives:
Describe basic wound care dressings that are on the market and available to patients. Recognize how and when to choose certain basic dressings. Demonstrate techniques of applying wound care basic dressings.
ANCC CE 1.0
DNA Awards & Business Meeting
11:30 AM - 1:00 PM
Role of the RN in Research and How the RN Works With the PI During Clinical Research
GS350 1:00 PM - 2:00 PM
Speakers: Harper Price, MD, FAAD, FAAP and Kellie Badger, BS, RN
We will be discussing the integral relationship and benefits of a nurse research coordinator and principal investigator in initiating and maintaining an active clinical research program.
Learning Objectives:
Describe the role that nurses have in clinical research and how that role interacts with the primary investigator and research team to run successful clinical trials.
ANCC CE 1.0
Speakers: Harper Price, MD, FAAD, FAAP and Kellie Badger, BS, RN
We will be discussing the integral relationship and benefits of a nurse research coordinator and principal investigator in initiating and maintaining an active clinical research program.
Learning Objectives:
Describe the role that nurses have in clinical research and how that role interacts with the primary investigator and research team to run successful clinical trials.
ANCC CE 1.0
Walking With Vitiligo: Stories of Strength and the Science of Treatment
GS360 2:00 PM - 3:00 PM
Speaker: Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP
This session pairs the lived experience of vitiligo advocate Tonja Johnson with the clinical expertise of dermatology nurse practitioner Dr. Patricia Delgado. Tonja will share her personal story of navigating life with vitiligo, highlighting the emotional strength, resilience, and community that shape the patient journey. Patricia will present an up-to-date, evidence-based review of vitiligo treatments, including topical therapies, phototherapy, systemic options, and newly emerging modalities. Together, they will illustrate how nurses can combine empathy, patient-centered communication, and scientific knowledge to support individuals living with vitiligo and optimize clinical outcomes.
Learning Objectives:
Analyze the psychosocial impact of vitiligo through areal patient narrative, including common emotional, social, and identity-related challenges experienced throughout the disease journey. Evaluate currentevidence-based treatments for vitiligo, including topical, phototherapy, systemic, and procedural modalities, as well as newly approved and emerging therapies. Integrate patient-centered communication strategies and shared decision-making principles to formulate individualized treatment plans that address both medical and psychosocial dimensions of vitiligo care.
ANCC CE 1.0 | Pharmacotherapeutics 0.5 - 30 Minutes
Sponsored by Photera
Speaker: Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP
This session pairs the lived experience of vitiligo advocate Tonja Johnson with the clinical expertise of dermatology nurse practitioner Dr. Patricia Delgado. Tonja will share her personal story of navigating life with vitiligo, highlighting the emotional strength, resilience, and community that shape the patient journey. Patricia will present an up-to-date, evidence-based review of vitiligo treatments, including topical therapies, phototherapy, systemic options, and newly emerging modalities. Together, they will illustrate how nurses can combine empathy, patient-centered communication, and scientific knowledge to support individuals living with vitiligo and optimize clinical outcomes.
Learning Objectives:
Analyze the psychosocial impact of vitiligo through areal patient narrative, including common emotional, social, and identity-related challenges experienced throughout the disease journey. Evaluate currentevidence-based treatments for vitiligo, including topical, phototherapy, systemic, and procedural modalities, as well as newly approved and emerging therapies. Integrate patient-centered communication strategies and shared decision-making principles to formulate individualized treatment plans that address both medical and psychosocial dimensions of vitiligo care.
ANCC CE 1.0 | Pharmacotherapeutics 0.5 - 30 Minutes
Sponsored by Photera
Topical Steroid Withdrawal: Where Are We Now?
GS370 3:15 PM - 4:15 PM
Speaker: Kelly Barta
While progress has been made in recent years to better understand Topical Steroid Withdrawal Syndrome (TSW), patient and caregiver concerns continue to escalate, and awareness of the condition is slow to reach health care practitioners. This session will provide an overview of the latest knowledge around the condition, current challenges in both medical and patient communities, and how dermatology nurses can best identify TSW and help patients suffering from this debilitating condition. There will be time for question and answers at the end of the presentation as well as an engaging activity in the sharing of knowledge as patient advocates and nurses to develop a patient and HCP friendly shared decision making tool in order to maximize the efficiency of clinical visits and mitigate patient stress.
Learning Objectives:
Identify current knowledge on TSW in the literature. Describe the patient community experience. Describe challenges facing HCPs and patients. Identify ways to help improve HCP/patient relationship and maximize clinical visits.
ANCC CE 1.0
Speaker: Kelly Barta
While progress has been made in recent years to better understand Topical Steroid Withdrawal Syndrome (TSW), patient and caregiver concerns continue to escalate, and awareness of the condition is slow to reach health care practitioners. This session will provide an overview of the latest knowledge around the condition, current challenges in both medical and patient communities, and how dermatology nurses can best identify TSW and help patients suffering from this debilitating condition. There will be time for question and answers at the end of the presentation as well as an engaging activity in the sharing of knowledge as patient advocates and nurses to develop a patient and HCP friendly shared decision making tool in order to maximize the efficiency of clinical visits and mitigate patient stress.
Learning Objectives:
Identify current knowledge on TSW in the literature. Describe the patient community experience. Describe challenges facing HCPs and patients. Identify ways to help improve HCP/patient relationship and maximize clinical visits.
ANCC CE 1.0
Thrive at Work and Never Burn Out
GS380 4:15 PM - 5:15 PM
Speaker: Vinh Chung MD, MTh, MPharmSci
We all want work that matters--work that feels meaningful, aligns with a greater purpose, and lets us go home whole. In medicine, burnout is everywhere, but it isn’t inevitable. It’s preventable, and in many cases, reversible.Thriving at work doesn’t happen by accident. It happens when we find the courage to pursue it. We must tie our work to a worthy mission and create a culture that fosters trust, connection, and growth. In this presentation, we’ll unpack what it actually takes to embrace our full humanity at work, so we can thrive. We will also discuss concrete steps to pursue work that energizes rather than drains you. We must never settle for a job. We must pursue our calling.
Learning Objectives:
Identify how to thrive at work.
ANCC CE 1.0
Speaker: Vinh Chung MD, MTh, MPharmSci
We all want work that matters--work that feels meaningful, aligns with a greater purpose, and lets us go home whole. In medicine, burnout is everywhere, but it isn’t inevitable. It’s preventable, and in many cases, reversible.Thriving at work doesn’t happen by accident. It happens when we find the courage to pursue it. We must tie our work to a worthy mission and create a culture that fosters trust, connection, and growth. In this presentation, we’ll unpack what it actually takes to embrace our full humanity at work, so we can thrive. We will also discuss concrete steps to pursue work that energizes rather than drains you. We must never settle for a job. We must pursue our calling.
Learning Objectives:
Identify how to thrive at work.
ANCC CE 1.0